Non-Hodgkin Lymphoma

  • Sara Alcorn
  • Harold Agbahiwe
  • Stephanie Terezakis
Part of the Medical Radiology book series (MEDRAD)


Non-Hodgkin lymphoma (NHL) is a heterogeneous group of B-cell, T-cell, and natural killer (NK)-cell neoplasms that lack the pathologic characteristics seen in Hodgkin disease (HD).


Clinical Target Volume Gross Tumor Volume Hodgkin Disease Thermoplastic Mask Deep Inspiration Breath Hold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Campbell BA et al (2010) Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer 116:3797–3806CrossRefPubMedGoogle Scholar
  2. Girinsky T et al (2006) Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79:270–277CrossRefPubMedGoogle Scholar
  3. Hodapp N (2012) The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 188:97–99CrossRefPubMedGoogle Scholar
  4. Illidge T, Specht L, Yahalom J (2014) Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group. IJROBP 89 (1):49–58CrossRefGoogle Scholar
  5. Marks LB et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19CrossRefPubMedPubMedCentralGoogle Scholar
  6. National Cancer Institute (2014) Adult non-Hodgkin lymphoma treatment (PDQ): cellular classification of adult NHL. Available at
  7. Pileri SA, Milani M, Fraternali-Orcioni G, Sabattini E (1998) From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 9:607–612CrossRefPubMedGoogle Scholar
  8. Rosenberg SA (1977) Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rep 61:‑1023–1027PubMedGoogle Scholar
  9. RTOG (2014) RTOG clinical trials listed by subject number. Available at
  10. Specht L et al (2013) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2013.05.005 CrossRefPubMedGoogle Scholar
  11. Swerdlow S et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARCGoogle Scholar
  12. White J et al. Breast cancer atlas for radiation therapy planning: consensus definitions. Available at
  13. Yahalom J, Mauch P (2002) The involved field is back: issues in delineating the radiation field in Hodgkin’s disease. Ann Oncol 13(Suppl 1):79–83CrossRefPubMedGoogle Scholar
  14. Yu J, Nam H et al (2010) Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. Int J Radiat Oncol Biol Phys 78:507–512CrossRefPubMedGoogle Scholar
  15. Zhang Y, et al (2012) Personalized assessment of kV cone beam computed tomography doses in image-guided radiotherapy of pediatric cancer patients. Int J Radiat Oncol Biol Phys 83:1649–1654CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Sara Alcorn
    • 1
  • Harold Agbahiwe
    • 2
  • Stephanie Terezakis
    • 1
  1. 1.Department of Radiation Oncology and Molecular Radiation SciencesThe Johns Hopkins HospitalBaltimoreUSA
  2. 2.Department of Radiation OncologySibley Memorial Hospital, Johns Hopkins MedicineWashington, DCUSA

Personalised recommendations